PROFUSA, INC. Operating Expenses
PROFUSA, INC. (PFSA) reported Operating Expenses of $2.54 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-19
- PROFUSA, INC. operating expenses for the quarter ending 2026-06-30 was $2.54M, a 153.74% increase year-over-year.
- PROFUSA, INC. operating expenses for the quarter ending 2026-03-31 was $4.01M, a 181.32% increase year-over-year.
- PROFUSA, INC. operating expenses for the quarter ending 2025-12-31 was $3.57M, a 229.94% increase year-over-year.
- PROFUSA, INC. operating expenses for the quarter ending 2025-09-30 was $21.71M, a 1742.87% increase year-over-year.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2.54M 10-Q · filed 2026-08-19 | $6.55M 10-Q · filed 2026-08-19 | $10.12M derived: sum of 3 quarters · filed 2026-08-19 | $31.83M derived: sum of 4 quarters · filed 2026-08-19 | ||
| 2026-03-31 | $4.01M 10-Q · filed 2026-05-15 | $7.58M derived: sum of 2 quarters · filed 2026-05-15 | $29.29M derived: sum of 3 quarters · filed 2026-05-15 | $30.29M derived: sum of 4 quarters · filed 2026-08-19 | ||
| 2025-12-31 | $3.57M derived: S-1/A 12 month − 10-Q 9 month · filed 2026-05-01 | $25.28M derived: sum of 2 quarters · filed 2026-05-01 | $26.28M derived: sum of 3 quarters · filed 2026-08-19 | $27.71M S-1/A · filed 2026-05-01 | ||
| 2025-09-30 | $21.71M 10-Q · filed 2025-11-19 | $22.71M derived: sum of 2 quarters · filed 2026-08-19 | $24.14M 10-Q · filed 2025-11-19 | $25.22M derived: sum of 4 quarters · filed 2026-08-19 | ||
| 2025-06-30 | $1.00M 10-Q · filed 2026-08-19 | $2.43M 10-Q · filed 2026-08-19 | $29.17K 10-Q · filed 2025-08-14 | $3.51M derived: sum of 3 quarters · filed 2026-08-19 | $4.69M derived: sum of 4 quarters · filed 2026-08-19 | |
| 2025-03-31 | $1.42M 10-Q · filed 2026-05-15 | $13.16K 10-Q · filed 2025-06-13 | $2.51M derived: sum of 2 quarters · filed 2026-05-15 | $3.68M derived: sum of 3 quarters · filed 2026-05-15 | ||
| 2024-12-31 | $1.08M derived: S-1/A 12 month − 10-Q 9 month · filed 2026-05-01 | $2.26M derived: sum of 2 quarters · filed 2026-05-01 | $4.60M S-1/A · filed 2026-05-01 | |||
| 2024-09-30 | $1.18M 10-Q · filed 2025-11-19 | $3.52M 10-Q · filed 2025-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |